# NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy

> **NCT06403267** · PHASE2 · RECRUITING · sponsor: **NoNO Inc.** · enrollment: 600 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** NoNO-42

## Key facts

- **NCT ID:** NCT06403267
- **Lead sponsor:** NoNO Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-02
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-07-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06403267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06403267, "NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06403267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*